1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
  5. > Competitor Analysis: Pim Kinase Inhibitors

Competitor Analysis: Pim Kinase Inhibitors

  • September 2013
  • -
  • La Merie Publishing
  • -
  • 17 pages

Competitor Analysis: Pim Kinase Inhibitors

Product description

The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cancer development and progression. These proteins are constitutively active once transcribed. Pim kinases are critical downstream effectors of the ABL, JAK2, and Flt-3 oncogenes and are required by them to drive tumorigenesis.

The present Competitive Intelligence report about Pim Kinase Inhibitorsprovides a competitor evaluation in the field of small molecule- and siRNA/miRNA-based inhibitors of the Pim Kinase for the treatment of cancer as of September 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of small molecule and siRNA/miRNA inhibitors of the Pim Kinases. In addition, the report lists company-specific R&D pipelines of Pim Kinase inhibitors.

Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Pim Kinase Inhibitors
Competitor Analysis: Pim Kinase Inhibitors

Table of Contents

• Pan-PIM Kinase Inhibitors
• Selective PIM-1 Kinase Inhibitors
• Dual PIM Kinase Inhibitors
• Not Specified PIM Kinase Inhibitors
• Dual Target PIM Kinase Inhibitors
• Corporate Pim Kinase Inhibitor RandD Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Multiple Myeloma Drugs Market 2017-2021

Global Multiple Myeloma Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About Multiple Myeloma Drugs Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins ...

Global and Chinese Erlotinib Hydrochloride (CAS 183319-69-9) Industry, 2017 Market Research Report

Global and Chinese Erlotinib Hydrochloride (CAS 183319-69-9) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Erlotinib Hydrochloride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Erlotinib Hydrochloride industry with ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Targeted Therapy Market in the UK

  • February 2017
    11 pages
  • Therapy  

    Targeted Therap...  

  • United Kingdom  

    Europe  

View report >

Therapy Market and Targeted Therapy Market in Canada

  • February 2017
    76 pages
  • Therapy  

    Targeted Therap...  

    Cancer Hormonal...  

  • Canada  

View report >

Therapy Market and Chemotherapy Market in Europe - Forecast

  • January 2017
    28 pages
  • Therapy  

    Chemotherapy  

    Breast Cancer  

  • Europe  

View report >

Chemotherapy Industry

2 months ago

Related Market Segments :

Targeted Therapy

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.